The following tables present our unaudited quarterly results of operations for each quarter within the two most recent fiscal years. This unaudited quarterly information has been prepared on the same basis as our audited consolidated financial statements and, in the opinion of management, the statement of operations data includes all adjustments, consisting of normal recurring adjustments, necessary for the fair presentation of the results of operations for these periods. The results of operations for any quarter are not necessarily indicative of the results of operations for any future periods.

	Fiscal 2017 Quarter Ended
	March 31, 2017			June 30, 2017			September 30, 2017			December 31, 2017
	(In thousands, except per share data)
Statements of Operations Data:
Revenue:
Product sales	$	3,900		$	4,416		$	13,662		$	14,128
License fees and consulting revenue		598			98			60			349
Grant revenue		83			81			272			396
Total revenue		4,581			4,595			13,994			14,873
Costs and operating expenses:
Cost of sales		2,839			4,137			8,082			10,064
Research and development expenses		26,408			17,597			11,944			20,848
Selling, general, and administrative expenses		9,799			13,632			10,364			12,317
Total costs and operating expenses		39,046			35,366			30,390			43,229
Operating loss		(34,465	)		(30,771	)		(16,396	)		(28,356	)
Net loss ⁽¹⁾		(41,025	)		(38,668	)		(23,308	)		(28,395	)
Less: net loss attributable to non-controlling interests		(37	)		(43	)		(34	)		(112	)
Net loss attributable to Athenex, Inc.	$	(40,988	)	$	(38,625	)	$	(23,274	)	$	(28,283	)
Net loss per share attributable to Athenex, Inc. common stockholders, basic and diluted	$	(1.01	)	$	(0.88	)	$	(0.41	)	$	(0.49	)

	Fiscal 2016 Quarter Ended
	March 31, 2016			June 30, 2016			September 30, 2016			December 31, 2016
	(In thousands, except per share data)
Statements of Operations Data:
Revenue:
Product sales	$	4,488		$	4,820		$	5,235		$	4,851
License fees and consulting revenue		95			71			76			150
Grant revenue		46			302			305			112
Total revenue		4,629			5,193			5,616			5,113
Costs and operating expenses:
Cost of sales		4,142			4,834			5,416			5,326
Research and development expenses		6,746			8,645			18,052			27,181
Selling, general, and administrative expenses		4,337			4,567			6,790			10,262
Total costs and operating expenses		15,225			18,046			30,258			42,769
Operating loss		(10,596	)		(12,853	)		(24,642	)		(37,656	)
Net loss ⁽¹⁾		(10,650	)		(12,499	)		(24,656	)		(40,101	)
Less: net loss attributable to non-controlling interests		(32	)		(78	)		(34	)		(47	)
Net loss attributable to Athenex, Inc.	$	(10,618	)	$	(12,421	)	$	(24,622	)	$	(40,054	)
Net loss per share attributable to Athenex, Inc. common stockholders, basic and diluted	$	(0.27	)	$	(0.31	)	$	(0.61	)	$	(0.98	)

Note (1): Results for the quarters ended September 30 and December 31, 2016 and March 31, June 30, and September 30, 2017 include interest expense and losses on derivative liabilities related to convertible notes.